<DOC>
	<DOCNO>NCT02812043</DOCNO>
	<brief_summary>This study aim compare efficacy safety amorolfine , long-pulsed Nd : YAG laser combination amorolfine long-pulsed Nd : YAG treat non-dermatophyte mixed-infection onychomycosis .</brief_summary>
	<brief_title>Comparison Between Long-pulsed Nd : YAG , Amorolfine Combination Treatment Treating Non-dermatophyte Onychomycosis</brief_title>
	<detailed_description>Onychomycosis common cause nail deformity result 50 % patient abnormal nail . From institution dermatology Thailand , confirm 1.7 % Thai population onychomycosis . Most patient age 40-60 year old female predominate . The common cause onychomycosis worldwide dermatophyte group , find 50 % patient . However , Thailand , study show 51.6 % patient onychomycosis infect non-dermatophyte group especially Neoscytalidium spp . The goal standard treatment onychomycosis oral anti-fungal drug Fluconazole , Itraconazole Terbinafine . But many patient limited oral medication due drug interaction CYP P2C9 inhibition statin , cause risk rhabdomyolysis hepatotoxicity . Even though medication effective dermatophytes . The non-dermatophytes leading pathogen onychomycosis Thailand tend resistant oral medication . Therefore topical modality become important role treat non-dermatophytes onychomycosis topical anti-fungals , topical urea cream laser treatment . So far , standard treatment make order treat non-dermatophyte onychomycosis cause problem patient physician Thailand . Amorolfine morpholine derivative use topical anti-fungal inhibits biosynthesis fungal cell membrane show fungicidal activity . From previous study , amorolfine effective topical treatment non-dermatophyte onychomycosis 52-55 % mycological cure rate clinical cure rate vary 12.7 % -54 % depend study . The side effect minimal application simple use . So amorolfine use first line treatment non-dermatophyte onychomycosis practice . However , long treatment ( 6 month 1 year ) low mycological cure rate new modality study deal problematic pathogen . Long-pulsed Nd : YAG laser use treat onychomycosis promise result . In 2013 , Kostas Kalokasidis use long-pulsed Nd : YAG onychomycosis show 94.5 % mycological cure rate relapse disease within 3 month . Later , Rungsima Wanitphakdeedecha M.D . try long-pulsed Nd : YAG treat onychomycosis find significant result long-pulsed Nd : YAG cure 95.42 % onychomycosis non-dermatophyte group . But protocol perform laser treatment every 2 week 1 month make difficult patient come hospital , moreover duration treat onychomycosis might need longer . So investigator come study compare efficacy long-pulsed Nd : YAG 4-week interval amorolfine combination Nd : YAG amorolfine see mycological result also clinical improvement . The treatment KOH examination fungal culture perform every month 4 month , follow 6 month first treatment</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Amorolfine</mesh_term>
	<criteria>1 . The patient age 18 year old . 2 . The patient diagnose nondermatophytes mixedinfection onychomycosis KOH examination fungal culture . 3 . The patient prior antifungal treatment within 6 month 4 . The patient receive vasodilator drug isotretinoin within 6 month 5 . The patient willing participate , accept method risk 1 . The patient suffer medical dermatologic condition associate onychomycosis psoriasis , paronychia etc . 2 . The patient take immunosuppressive drug , immunocompromised host . 3 . The patient severe vascular disease , severe DVT , poor capillary refill time . 4 . The patient onychomycosis involve nail matrix . 5 . Pregnancy lactation . 6 . The patient problem communication difficulty travel faculty checkup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>onychomycosis</keyword>
	<keyword>amorolfine</keyword>
	<keyword>long-pulsed Nd : YAG</keyword>
	<keyword>fungal infection</keyword>
</DOC>